These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16523070)

  • 41. Transient neutropenia induced by intravenous immune globulin.
    Ben-Chetrit E; Putterman C
    N Engl J Med; 1992 Jan; 326(4):270-1. PubMed ID: 1727981
    [No Abstract]   [Full Text] [Related]  

  • 42. Intravenous immune globulin.
    Med Lett Drugs Ther; 1992 Dec; 34(886):116-8. PubMed ID: 1465040
    [No Abstract]   [Full Text] [Related]  

  • 43. Intravenous immune globulin and aseptic meningitis.
    Rao SP; Teitlebaum J; Miller ST
    Am J Dis Child; 1992 May; 146(5):539-40. PubMed ID: 1306046
    [No Abstract]   [Full Text] [Related]  

  • 44. Transmission of viral infections through intravenous immune globulin.
    Schiff RI
    N Engl J Med; 1994 Dec; 331(24):1649-50. PubMed ID: 7969346
    [No Abstract]   [Full Text] [Related]  

  • 45. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura.
    Law C; Marcaccio M; Tam P; Heddle N; Kelton JG
    N Engl J Med; 1997 May; 336(21):1494-8. PubMed ID: 9154768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Indications for intravenous immunoglobulins].
    Spertini F
    Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
    [No Abstract]   [Full Text] [Related]  

  • 47. A case of diffuse scleroderma successfully treated with high-dose intravenous immune globulin infusion.
    Asano Y; Ihn H; Asashima N; Yazawa N; Mimura Y; Jinnin M; Yamane K; Tamaki K
    Rheumatology (Oxford); 2005 Jun; 44(6):824-6. PubMed ID: 15769789
    [No Abstract]   [Full Text] [Related]  

  • 48. Hepatitis C and immune globulin.
    Douglas SD; Slade HB
    N Engl J Med; 1995 May; 332(18):1235; author reply 1236-7. PubMed ID: 7700323
    [No Abstract]   [Full Text] [Related]  

  • 49. Meningitis and skin reaction after intravenous immune globulin therapy.
    Gabor EP
    Ann Intern Med; 1997 Dec; 127(12):1130. PubMed ID: 9412322
    [No Abstract]   [Full Text] [Related]  

  • 50. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Ogata S; Bando Y; Kimura S; Ando H; Nakahata Y; Ogihara Y; Kaneko T; Minoura K; Kaida M; Yokota Y; Furukawa S; Ishii M
    J Cardiol; 2009 Feb; 53(1):15-9. PubMed ID: 19167633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High dose intravenous immune globulin in the treatment of hereditary recurrent brachial plexus neuropathy.
    Ardolino G; Barbieri S; Priori A
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):550; author reply 550-1. PubMed ID: 12640095
    [No Abstract]   [Full Text] [Related]  

  • 52. Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura.
    Al-Riyami AZ; Lee J; Connolly M; Shereck E
    Pediatr Blood Cancer; 2011 Jul; 57(1):157-9. PubMed ID: 21445949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous Rh(o) [D] immune globulin [human] (WinRho SDF): suspected hemolytic/renal adverse reactions.
    Parker C
    CMAJ; 2000 Oct; 163(7):881, 885. PubMed ID: 11033724
    [No Abstract]   [Full Text] [Related]  

  • 54. Intravenous immune globulin and pseudohyponatremia.
    Lawn N; Wijdicks EF; Burritt MF
    N Engl J Med; 1998 Aug; 339(9):632. PubMed ID: 9722438
    [No Abstract]   [Full Text] [Related]  

  • 55. Recurrent migraine and intravenous immune globulin therapy.
    Constantinescu CS; Chang AP; McCluskey LF
    N Engl J Med; 1993 Aug; 329(8):583-4. PubMed ID: 8336767
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis C and immune globulin.
    López-Jiménez J; Odriozola J; Pérez-Oteyza J; García-Laraña J
    N Engl J Med; 1995 May; 332(18):1235-6. PubMed ID: 7700324
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of stiff-man syndrome with intravenous immune globulin.
    Karlson EW; Sudarsky L; Ruderman E; Pierson S; Scott M; Helfgott SM
    Arthritis Rheum; 1994 Jun; 37(6):915-8. PubMed ID: 8003064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meningitis and skin reaction after intravenous immune globulin therapy.
    Catteau B; Delaporte E; Piette F
    Ann Intern Med; 1997 Dec; 127(12):1130. PubMed ID: 9412321
    [No Abstract]   [Full Text] [Related]  

  • 59. IGIV: blood product linked to clotting problems.
    Nursing; 2002 Oct; 32(10):26. PubMed ID: 12402895
    [No Abstract]   [Full Text] [Related]  

  • 60. Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy.
    Donofrio PD; Bril V; Dalakas MC; Deng C; Hanna K; Hartung HP; Hughes R; Latov N; Merkies I; van Doorn P;
    Arch Neurol; 2010 Sep; 67(9):1082-8. PubMed ID: 20837852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.